Dr. Bishoy M. Faltas @FaltasLab Twitter profile

Pinned Tweet

Dr. Bishoy M. Faltas

1 month

1/ Thrilled to take on this new role as Chief Research Officer of the Englander Institute for Precision Medicine @WCMEnglanderIPM @WeillCornell

WCM Englander Institute for Precision Medicine

@WCMEnglanderIPM

1 month

Please join us in congratulating our colleague Dr. Bishoy M. Faltas ( @FaltasLab ) on being named the @WCMEnglanderIPM 's Chief Research Officer by our Director Olivier Elemento, Ph.D. ( @ElementoLab )! #PrecisionMedicine

11

79

63

22

273

Last Seen Profiles

@Yasya_karlikova

@i_m_the_one1

@CyBORg_BTC

@RMantri

@TwfyqY40441

@MeekMill

@zkdayofficial

@offguning

@soybiatrois

@fpl_4

@didasportsorg

@tavionthomas937

@eyqshen

@NowoCraft

@JoeniaWapichana

@FoxieMoose

@patatareport_

@WillHutch16

@abuelyazia

@meiridasai0

@Joecreampie

@AlcaldiaArmenia

@leetorihiki0102

@CadeCothren

@seldomaf

@abhishu2603

@IshaSamskriti

@iamcaseydale

@de_anarky

@salenamo30678

@Binzbysolange

@Toshi_Tools

@HEESEUUNNG

@hernandez_lab

@KSJRVAU

@CryptoAPLP

Dr. Bishoy M. Faltas

@FaltasLab

8 months

I am excited to share we have received the NoA of an R01, converted to the prestigious MERIT R37. Grateful for the @NIH @theNCI 's funding for the next 7 years! This will support our work on targeting APOBEC3 cytidine deaminases as drivers of resistance in #bladdercancer

75

16

349

Dr. Bishoy M. Faltas

@FaltasLab

3 years

Very proud of our new paper: Common germline-somatic variant interactions in advanced urothelial cancer Tweetorial to follow.

24

66

319

Dr. Bishoy M. Faltas

@FaltasLab

2 years

Excited to share our new @biorxivpreprint : The evolution of genomic, transcriptomic, and immune features of metastatic upper tract urothelial carcinoma . A #Teamscience project spearheaded by K. Ohara and co-led by @FaltasLab and J.M. Mosquera

15

76

291

Dr. Bishoy M. Faltas

@FaltasLab

2 years

Excited to share our new paper on using serial ctDNA to predict progression in patients with metastatic #bladdercancer @BrJCancer led by mentee @Kyrillus2 Great collaboration with @sonpavde @PGrivasMDPhD , Nick Vogelzang and others @WeillCornell

17

58

261

Dr. Bishoy M. Faltas

@FaltasLab

1 year

Pre-print alert 🚨Excited to share our new preprint “The interplay between mutagenesis and extrachromosomal DNA shapes urothelial cancer evolution” 🧬🔬 #bladdercancer @OncoAlert

19

76

249

Dr. Bishoy M. Faltas

@FaltasLab

2 years

Pre-print alert 🚨 New story from my lab "The cytidine deaminase APOBEC3G drives cancer mutagenesis and clonal evolution in bladder cancer" This is one of the first projects in my lab, so I am thrilled to see it come to fruition 🐁🧪 🔬 #bladdercancer #biology @OncoAlert

22

50

245

Dr. Bishoy M. Faltas

@FaltasLab

2 months

Excited to share our new paper just published @NatureComms @WCMGUcancer @WeillCornell Great collaboration between my lab with @ElementoLab @WCMEnglanderIPM and J.M. Mosquera @WCMCPathology 🔬 Full tweetorial below with more updates to come. Stay tuned!

Dr. Bishoy M. Faltas

@FaltasLab

2 years

Excited to share our new @biorxivpreprint : The evolution of genomic, transcriptomic, and immune features of metastatic upper tract urothelial carcinoma . A #Teamscience project spearheaded by K. Ohara and co-led by @FaltasLab and J.M. Mosquera

15

76

291

17

41

213

Dr. Bishoy M. Faltas

@FaltasLab

6 months

Honored and delighted to receive the 2023 @UrologySBUR Young Investigator Award given to SBUR members under the age of 45 who "have made significant contributions to Urologic Research." #SBUR23 in San Antonio.

38

13

207

Dr. Bishoy M. Faltas

@FaltasLab

1 year

We‘ve made the cover of Cancer Research @CR_AACR 🎉 Thank you @CharlesSwanton and @drmcaswell for highlighting our paper on APOBEC3 #bladdercancer mouse models! Check out the paper and fantastic commentary ⬇️ @OncoAlert @WeillCornell

11

32

196

Dr. Bishoy M. Faltas

@FaltasLab

11 months

Very proud dad today! Got to accompany my 13 year old son @NasdaqExchange opening bell 🔔 ceremony. He was invited as a silver key awardee of @artandwriting Scholastic Awards as part of their 100th year celebration

21

3

179

Dr. Bishoy M. Faltas

@FaltasLab

1 year

Dinner with oncology legend Dr. Lawrence Einhorn. Hundreds of thousands of men are alive today because of his pioneering work that led to curing testicular cancer. Humility, impact and wisdom!

10

29

175

Dr. Bishoy M. Faltas

@FaltasLab

5 years

Very proud of the latest @Faltaslab paper on the biology of upper tract urothelial carcinoma @NatureCommunications @surrealistNYC @Panos_Vlach @ElementoLab @cornellGUcancer @nyphospital @WeillCornell Stay tuned for the Twitter explainer.

18

34

157

Dr. Bishoy M. Faltas

@FaltasLab

9 months

Great news! 🎉 Very grateful 🙏to the @CDMRP for funding our work on APOBECs as drivers of metastasis in #bladdercancer . Thanks to the reviewers for a perfect score! My lab is hiring postdocs to work on these exciting projects! Please spread the word 📢

24

26

153

Dr. Bishoy M. Faltas

@FaltasLab

1 year

Excited to share our new paper just published in Cancer Research @CR_AACR @weisi_liu , @knewtrophil @FKhaniPath @DrLaMontBarlow @DuyDNguyen1 L. Gu K. Eng @BhavneetBhinder @MDUppal92 @ChRecapet @asbonerw S. Ross @ElementoLab @ChelicoUSASK

24

25

146

Dr. Bishoy M. Faltas

@FaltasLab

6 months

A lot to be grateful for this Thanksgiving. Thanks to my lab members, colleagues and family for their continued support

Weill Cornell Medicine

@WeillCornell

6 months

A MERIT grant was awarded to Dr. Bishoy Faltas ( @FaltasLab ) from @theNCI at @NIH to study mutations that drive bladder cancer. "This prestigious award will allow us to pursue more high-risk, high-reward angles," says Dr. Faltas of @WCMEnglanderIPM .

5

6

76

11

10

141

Dr. Bishoy M. Faltas

@FaltasLab

2 years

Thank you @the_asci for this award. Grateful for support from mentors, #Faltaslab members and colleagues @cornellGUcancer @WCMEnglanderIPM @WeillCornell @nyphospital @AACRPres

Weill Cornell Medicine

@WeillCornell

2 years

Three #WCM faculty members have received Young Physician-Scientist Awards from the American Society for Clinical Investigation ( @the_asci ). Congratulations to Drs. Bishoy M. Faltas ( @FaltasLab ), Gunisha Kaur ( @GunishaKaur ) and Hasina Outtz Reed.

0

11

72

32

5

139

Dr. Bishoy M. Faltas

@FaltasLab

1 year

🚀 Exciting opportunity alert! My Lab at Weill Cornell 🏥 is seeking postdoctoral candidates in cancer biology 🔬 and bioinformatics 💻! Full ad here: #PhD #postdoc #phdstudent #phdchat spread the word 📣 by retweeting and sharing!

2

77

124

Dr. Bishoy M. Faltas

@FaltasLab

10 months

A great day hosting the legend @DrChoueiri who is visiting us at @WeillCornell from @DanaFarber @harvardmed Amazing to see all the progress for patients with kidney cancers led by Toni and his team and to collaborate on more advances for patients!

1

15

120

Dr. Bishoy M. Faltas

@FaltasLab

1 year

Very grateful for new funding from the Starr Cancer Consortium. Exciting project led by postdoc @Rahul_RaSingh in my lab 👏Looking forward to collaborating with @Samuel_Bakhoum and @mittallab to define the role of the APOBEC3 enzymes in metastasis @WeillCornell

WCM Englander Institute for Precision Medicine

@WCMEnglanderIPM

1 year

Congrats to Dr. Bishoy Faltas ( @FaltasLab ), Dir. of Bladder Cancer Research @WCMEnglanderIPM , on his new Starr Cancer Consortium award to study "Targeting cytidine deaminase-induced chromosomal instability as a driver of metastasis in #bladdercancer "!

5

7

64

12

2

118

Dr. Bishoy M. Faltas

@FaltasLab

4 months

Had a lot of fun presenting our work @ASCO #GU24 featuring a deep learning model 🔗fusing outputs of 3 neural networks trained on pathology images 🔬+ gene expression 🧬+ spatial cell data from patients with bladder cancer to predict clinical trial responses to chemotherapy.

Dr. Bishoy M. Faltas

@FaltasLab

4 months

Excited to present our work @ASCO #GU24 A collaboration b/w @FaltasLab @ElementoLab @feiwang03 & S1314 team. We built a deep learning model to 🔗fuse 3 neural networks trained on pathology images 🔬+ gene expression 🧬+ spatial cell data to predict clinical trial outcomes

4

20

90

4

16

116

Dr. Bishoy M. Faltas

@FaltasLab

8 years

Proud of our study defining how chemotherapy directs #bladder #cancer evolution @WeillCornell @engIPM

4

38

111

Dr. Bishoy M. Faltas

@FaltasLab

7 months

Historic advance in the treatment of patients with metastatic bladder cancer. The first time a treatment improves outcomes compared to first-line chemotherapy- took more than 30 years! Congratulations to @tompowles1 and the team

Elizabeth Plimack MD

@ERPlimackMD

7 months

Applause mid-presentation marking the moment the standard of care changed in #bladdercancer The data speaks for itself, but @tompowles1 spoke for all of us thanking patients, not just those on EV 302, but the many who came before allowing us to celebrate this milestone #EVPembro

14

148

769

1

19

112

Dr. Bishoy M. Faltas

@FaltasLab

7 months

Very grateful for the funding from @CDMRP @DeptofDefense to study the role of APOBEC3 in bladder metastasis. Thanks @WeillCornell for highlighting our work

Weill Cornell Medicine

@WeillCornell

7 months

A grant from the @DeptofDefense was awarded to researchers at @WCMEnglanderIPM and @WCM_MeyerCancer led by Dr. Bishoy Faltas ( @FaltasLab ) to study the mechanisms that drive the spread of bladder cancer.

2

3

28

8

6

108

Dr. Bishoy M. Faltas

@FaltasLab

3 years

Excited to share our new paper @Kyrillus2 @iRonB25 @davidwilkes1965 @PrincescaD @ElementoLab A. Alonso @asbonerw and others.

8

16

104

Dr. Bishoy M. Faltas

@FaltasLab

5 years

I collected some of the best moments of @ASCO #GU19 ⚡️ “ASCO Genitourinary Cancers Symposium wrap-up” Enjoy!

6

37

102

Dr. Bishoy M. Faltas

@FaltasLab

2 years

Thank you @ASCO #ASCO22 for bringing oncologists together to advance #bladdercancer research and patient care. 👋 Bye #Chicago

5

3

99

Dr. Bishoy M. Faltas

@FaltasLab

3 years

Our #ASCO #GU21 abstract: we used single-cell DNA sequencing to characterize the evolution of patient-derived #bladdercancer organoids under selective pressure from targeted therapy @Kyrillus2 @weisi_liu @MLauritamartin @ElementoLab @EngIPM @MissionBio @FaltasLab @cornellGUcancer

3

34

100

Dr. Bishoy M. Faltas

@FaltasLab

4 years

Honored to be in the @WeillCornell magazine. The real story is that of my brave patient featured in this article. She had urothelial cancer in both kidneys, had surgery, and adjuvant chemo. Finally, she got a kidney transplant. We have a lot of work to do for UC patients

WCM Englander Institute for Precision Medicine

@WCMEnglanderIPM

4 years

Congratulations to @EngIPM Member Bishoy Faltas, M.D. ( @FaltasLab ) on his profile in the Weill Cornell Medicine Summer 2020 Magazine:

2

6

32

4

11

98

Dr. Bishoy M. Faltas

@FaltasLab

4 months

Leaving @ASCO #GU24 with much gratitude for many meaningful moments and ready to get back to work together against #bladdercancer 💪 @WeillCornell . One such moment is conversation with oncology superstars @DrChoueiri @tompowles1 in the speaker ready room before my talk!

4

9

94

Dr. Bishoy M. Faltas

@FaltasLab

3 months

Very proud of FaltasLab technician @DuyDNguyen1 who just got accepted into the Ph.D. program @BBS_Harvard @HarvardGSAS #proudPI

6

93

Dr. Bishoy M. Faltas

@FaltasLab

5 years

Twitter explainer for our paper @NatureComms on upper tract urothelial carcinoma. Part I:

2

33

90

Dr. Bishoy M. Faltas

@FaltasLab

4 months

Excited to present our work @ASCO #GU24 A collaboration b/w @FaltasLab @ElementoLab @feiwang03 & S1314 team. We built a deep learning model to 🔗fuse 3 neural networks trained on pathology images 🔬+ gene expression 🧬+ spatial cell data to predict clinical trial outcomes

4

20

90

Dr. Bishoy M. Faltas

@FaltasLab

6 years

Very proud of our review @NatRevClinOncol of the evolutionary forces that drive resistance to #bladdercancer @PanosV_pjv9003 @cornellGUcancer

NatureRevClinOncol

@NatRevClinOncol

6 years

Treatment resistance in urothelial carcinoma: an evolutionary perspective - @NatResCancer #cagenome #blcsm

1

13

19

5

30

89

Dr. Bishoy M. Faltas

@FaltasLab

2 years

Excited to co-chair #BCANTT22 with the amazing @SimaPorten This is a photo from our last in-person Think Tank 3 years ago! @BladderCancerUS brings together outstanding clinicians, scientists, and patient advocates. Let's work together to cure #bladdercancer @bcan_chisolm

Dr. Bishoy M. Faltas

@FaltasLab

5 years

Wonderful group of researchers, patient advocates and organizers at #BCANTT19 @BladderCancerUS that are working together to improve outcomes for #bladdercancer patients. Looking forward to participating with @MattGalsky @SimaPorten and others to organize #BCANTT20

3

21

66

8

21

88

Dr. Bishoy M. Faltas

@FaltasLab

4 years

Glad to contribute to this review on my favorite topic in #bladdercancer biology: tumor heterogeneity Fantastic effort by @JoshMeeks @LDyrskjot @h_alahmadie @djmcconkey @DavidDeGraff5 et al. @NatRevUrol & Albert Institute for Bladder Cancer @UroDocAsh

2

31

85

Dr. Bishoy M. Faltas

@FaltasLab

2 years

Honored to give the keynote lecture at the 'Genomics: Translating into Clinical Practice' #bladdercancer session at #SUO21 @UroOnc . Expect amazing talks @IyerGopa @DrJohnSfakianos @pcvblack @heather_chalfin Thanks to S. Lerner & @apolo_andrea organizing

2

17

82

Dr. Bishoy M. Faltas

@FaltasLab

3 years

The Faltas Lab has two open postdoctoral positions. If you are excited about genomics, the mechanisms that generate mutational signatures and germline mutations in #bladdercancer , come to join us #RETWEEET

0

49

82

Dr. Bishoy M. Faltas

@FaltasLab

4 years

Honored to receive this grant to study the immunogenomic determinants of ethnic disparities in clinical outcomes in #bladdercancer patients @polyethnic1000 @ElementoLab @Kyrillus2 @DrDavidNanus @JamesJmm23 @nyphospital @EngIPM @TheMarkFdn @nygenome @notSoJunkDNA @WeillCornell

NY Genome Center

@nygenome

4 years

NYGC Launches Collaborative Cancer Genomics Research Projects Focused on Underserved Populations: @cshl @IcahnMountSinai @KingsCountyHosp @nyphospital @nygenome @NYPBrooklyn @NorthwellHealth @sunydownstate @WeillCornell @illumina @NYCommTrust

2

11

39

10

6

82

Dr. Bishoy M. Faltas

@FaltasLab

4 years

I know that this May is different that any other but, it is still #Bladdercancerawareness month. We need to continue to spread awareness about this disease. We are making huge advances but there is a lot more to be done.

3

20

81

Dr. Bishoy M. Faltas

@FaltasLab

5 months

Look who just dropped into my office! Thrilled to welcome the amazing @montypal to WCM, straight from sunny California! ☀️Always learn a lot from his insights and wisdom. Plus, I even got the chance to capture a 'Thinking Monty' moment right beside the legendary Dr. Papanicolaou!

2

10

81

Dr. Bishoy M. Faltas

@FaltasLab

10 months

Therapy-induced APOBEC3A drives evolution of persistent cancer cells | Nature

Therapy-induced APOBEC3A drives evolution of persistent cancer cells

Nature - Induction of APOBEC3A in response to targeted therapies drives evolution of drug-tolerant persister cells, suggesting that its suppression may represent a potential therapeutic strategy in...

www.nature.com

1

19

80

Dr. Bishoy M. Faltas

@FaltasLab

2 years

Great to catch up with friends, share our latest work, discuss the advances being made by the #bladdercancer research community and learn from patients at #BCANTT22 @BladderCancerUS See you next year in DC!

5

3

74

Dr. Bishoy M. Faltas

@FaltasLab

5 years

As an oncologist, nothing is more satisfying than realizing that your patient has now turned one year older and hit an important milestone with no evidence of cancer #defeatbladdercancer

1

12

74

Dr. Bishoy M. Faltas

@FaltasLab

2 years

Congratulations ⁦⁦ @JoshMeeks ⁩ great work ! Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma | Science Advances

Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma

EZH2 inhibition in bladder cancer strongly reduces tumor progression only through suppression of an adaptive immune response.

www.science.org

3

11

72

Dr. Bishoy M. Faltas

@FaltasLab

4 years

Proud to share our new review on the recent advances molecular biology of UTUC @EUplatinum . Great collaboration with Melanie Hassler @FreddieBray_ @JimCatto @SurenaMatinMD @MRoupret @DrJohnSfakianos @DrShariat and others @univienna @cornellGUcancer

1

28

72

Dr. Bishoy M. Faltas

@FaltasLab

1 year

Excited to be part of this review on circulating and urinary tumor DNA in UC @KyleRoseMD @HHuelsterMD @JoshMeeks @sonpavde @slernerbcmedu1 J. Ross @SpiessPhilippe @gdgrass @rohitjainMD @UroDocAsh A. Vosoughi L. Wang @xuefwang @UrogerliMD

Circulating and urinary tumour DNA in urothelial carcinoma — upper tract, lower tract and metasta...

Nature Reviews Urology - Non-invasive liquid biopsies such as plasma circulating tumour DNA (ctDNA) and urinary tumour DNA (utDNA) are promising tools for urothelial carcinoma diagnosis and...

www.nature.com

2

15

72

Dr. Bishoy M. Faltas

@FaltasLab

10 months

Thrilled to kick-off the 18th annual @BladderCancerUS #BCANTT23 in just 4 days! 🗓️Honored to chair the premier bladder cancer meeting with @eugene_pietzak in Washington DC. Excited to see friends, exchange ideas and discuss the latest in #bladdercancer research!

7

22

70

Dr. Bishoy M. Faltas

@FaltasLab

4 years

Glad to collaborate with @DrJohnSfakianos @jorgedaza87 @ElementoLab @NYCRoboticTeam @MattGalsky David Mulholland on this paper that examines the lineage plaplasticity underlying bladder cancer molecular subtypes using single-cell sequencing @NatureComms

Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers

Nature Communications - Recent studies have utilized bulk tumour mRNA sequencing to classify bladder cancers into distinct subgroups. Here, the authors use single cell transcriptomic analysis and...

www.nature.com

4

25

71

Dr. Bishoy M. Faltas

@FaltasLab

7 months

Enjoyed my meeting with visiting professor Dr. Eila Skinner who is visiting @WCMUrology from @StanfordUrology

0

4

68

Dr. Bishoy M. Faltas

@FaltasLab

4 years

My comments in the @NYT on the importance of understanding the effects of genetic diversity on treatment responses in #bladdercancer patients @WeillCornell

The New York Times

@nytimes

4 years

Decades of genetic studies have focused mainly on white patient populations. Now, new research grants have been awarded to projects examining the role of race and ethnicity in major types of cancer.

31

162

651

0

8

68

Dr. Bishoy M. Faltas

@FaltasLab

2 years

Our @ASCO #GU22 abstract presented by #FaltasLab mentee and @ConquerCancerFd merit award recipient @Kyrillus2 : Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma . Now published @

2

20

67

Dr. Bishoy M. Faltas

@FaltasLab

2 years

Always great to collaborate with @DrRosenbergMSK @MSKCancerCenter

WCM Englander Institute for Precision Medicine

@WCMEnglanderIPM

2 years

Congrats to Dr. Bishoy Faltas ( @FaltasLab ), @WCMEnglanderIPM 's Dir. of Bladder Cancer Research and @MSKCancerCenter 's Dr. Jonathan Rosenberg on their new @WCMC_CTSC Pilot Award for their proposal: "Reinterpreting the pathogenicity of VUS in UC patients from diverse ancestries."

1

4

28

9

4

65

Dr. Bishoy M. Faltas

@FaltasLab

5 years

Wonderful group of researchers, patient advocates and organizers at #BCANTT19 @BladderCancerUS that are working together to improve outcomes for #bladdercancer patients. Looking forward to participating with @MattGalsky @SimaPorten and others to organize #BCANTT20

3

21

66

Dr. Bishoy M. Faltas

@FaltasLab

2 years

"Cancer immunotherapy is generating huge excitement, but the future may lie elsewhere, in antibody–drug conjugates, proteolysis-targeting chimeras, and liquid biopsy for early detection"

0

10

64

Dr. Bishoy M. Faltas

@FaltasLab

3 months

Looking forward to my visit to @kochinstitute @MIT Thanks @fjsanchezrivera for the invitation

1

11

65

Dr. Bishoy M. Faltas

@FaltasLab

4 years

Today @weisi_liu and I gathered extra glove boxes from @FaltasLab and donated to @WeillCornell oncology clinic. Please consider donating extra PPE to healthcare workers at your medical center 🏥 to protect them against #COVID19

0

8

65

Dr. Bishoy M. Faltas

@FaltasLab

3 years

Yearlong Leadership in Academic Medicine Program (LAMP) @WeillCornell completed ✅. Learned a lot and made some new friends along the way. Thank you @JudyTungMD for leading this exceptional program and @DrMhidalgo @thollenbergmd K.Hajjar @AugustineMKChoi for supporting it. #WCM

3

0

65

Dr. Bishoy M. Faltas

@FaltasLab

5 months

Enjoyed participating in this session @KSMurrayUro , @SurenaMatinMD , @FaltasLab , @Dr_Jen_Linehan , @JCensits @HougenHY @JoshMeeks at #SUO23 discussing our current understanding of the biology of upper tract urothelial cancer and how it is already translating into clinical advances

1

10

63

Dr. Bishoy M. Faltas

@FaltasLab

7 months

📘 Honored to guest edit this @UrolOncol Special Issue on advances in UC treatments ➡️ Featuring articles by @DrJonesNauseef @DrScottTagawa @kalasri3 @CChuMD @eugene_pietzak @TiansterZhang @ZeynepZengin @montypal et al. on ADCs, FGFR3i, IO & toxicities.

1

24

61

Dr. Bishoy M. Faltas

@FaltasLab

4 years

I still can't bake anything edible, but I can now run a phylogenetic analysis of #bladdercancer whole-exome data and make trees in #R #Rlearning #CancerEvolution #pandemiclearning

3

0

63

Dr. Bishoy M. Faltas

@FaltasLab

5 years

Faltas Lab receives a Developmental Research Program Award from MSKCC's Bladder SPORE . We are excited to collaborate with Drs. @DSolit , Bajorin @h_alahmadie , Funt, @IyerGopa , @MichaelGlickma1 , Rosenberg on this exciting project @EngIPM @cornellGUcancer

8

2

63

Dr. Bishoy M. Faltas

@FaltasLab

5 months

⁩Enjoyed the opportunity to discuss w @weillcornell Dean Harrington @HeartBobH our collaboration w @WCMEnglanderIPM & @ElementoLab to improve the lives of patients with #bladdercancer . Vision to integrate AI and spatial profiling technologies w clinical trials in real-time

0

14

60

Dr. Bishoy M. Faltas

@FaltasLab

3 years

Excited to give the state-of-the-art lecture at #EAU21 on Germline mutations and urothelial cancer management. Looking forward to discussion with @GNiegisch and @pcvblack

1

18

60

Dr. Bishoy M. Faltas

@FaltasLab

5 years

Announcement: I am honored to join the editorial board of @BladderCaJrnl as the social media editor. If you are not already, please follow @BladderCaJrnl , the official journal of @B_C_A_N on Twitter #SoMe @IOSPress_STM

2

5

60

Dr. Bishoy M. Faltas

@FaltasLab

2 years

Awesome discussion with amazing scientist, friend and newly inducted @the_asci member @HsiehLab Congratulations Andrew! @JointMeeting #ASCI22

3

1

59

Dr. Bishoy M. Faltas

@FaltasLab

1 year

#Bladdercancer organoids as a functional system to model disease stages & therapy response ⁦ @NatureComms ⁩ Congratulations ⁦ @paola_gasperini ⁩ @FrancescaBZNY ⁩ @Roland3097 ⁦ @evacomperat ⁩ @MariannKruithof ⁩ et al. on this tour de force

Bladder cancer organoids as a functional system to model different disease stages and therapy...

Nature Communications - Bladder cancer heterogeneity can limit treatment efficacy in individual patients. Here, the authors use patient derived organoids to develop a drug screening pipeline and...

www.nature.com

3

13

57

Dr. Bishoy M. Faltas

@FaltasLab

5 years

1-Patients with urothelial cancer whose disease progresses after chemotherapy and immunotherapy have no approved treatments at this point. We have been working hard to develop new treatments for these patients. @ASCO #GU19 in a multi-center study @DrScottTagawa @cornellGUcancer

2

28

59

Dr. Bishoy M. Faltas

@FaltasLab

3 years

Excited to be the discussant for three excellent #bladdercancer abstracts by @PGrivasMDPhD Sam Funt @tompowles1 at #ASCO21 . I will review the amazing progress of #immunotherapy neoadjuvant and maintenance trials and my take on molecular subtypes as response biomarkers.

0

8

59

Dr. Bishoy M. Faltas

@FaltasLab

2 months

Grateful to @nyphospital for profiling our research #FaltasLab & our vision to improve #BladderCancer patient outcomes by building a world-class research program @WeillCornell . Read more here:

1

14

58

Dr. Bishoy M. Faltas

@FaltasLab

2 years

Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge | Nature Medicine

0

18

58

Dr. Bishoy M. Faltas

@FaltasLab

7 years

Big news: my lab will open @WeillCornell specializing in #bladder #cancer #evolution and #Genomics @cornellGUcancer @B_C_A_N @FaltasLab

13

6

57

Dr. Bishoy M. Faltas

@FaltasLab

1 year

Few things are better than getting a visit from your mentor. Seems like it was yesterday when I was a postdoc in @MarkARubin1 ‘s lab. It was great to catch up!

2

0

57

Dr. Bishoy M. Faltas

@FaltasLab

2 years

More GU oncologists @DrRosenbergMSK @shilpaonc @ASCO #ASCO2022

4

3

57

Dr. Bishoy M. Faltas

@FaltasLab

6 years

The husband of my late patient stopped by. He was thankful that she had 18 more months to live because of a clinical trial I enrolled her in. He quit his job, they spent time together and traveled a lot. We need more #bladdercancerresearch because life is short @cornellGUcancer

2

8

56

Dr. Bishoy M. Faltas

@FaltasLab

2 years

Progress in the treatment of genitourinary cancers has been nothing short of extraordinary in 2021...the fruits of translational advances are built on foundations of basic science that require serious investments and take years in the making @ASCOPost

2

18

57

Dr. Bishoy M. Faltas

@FaltasLab

5 years

Congratulations to @Panos_Vlach who just graduated from @WeillCornell Hem/Onc fellowship and is joining us as a faculty member @cornellGUcancer with @DrScottTagawa @DrDavidNanus @cnsternberg @DrAnaMolina #proudmentor

9

6

57

Dr. Bishoy M. Faltas

@FaltasLab

9 months

We are hiring- please retweet

Dr. Bishoy M. Faltas

@FaltasLab

1 year

🚀 Exciting opportunity alert! My Lab at Weill Cornell 🏥 is seeking postdoctoral candidates in cancer biology 🔬 and bioinformatics 💻! Full ad here: #PhD #postdoc #phdstudent #phdchat spread the word 📣 by retweeting and sharing!

2

77

124

3

49

56

Dr. Bishoy M. Faltas

@FaltasLab

5 years

Today @GoogleDoodles honors Dr. Papanikolaou, the Greek cytopathologist who worked with his wife to develop the life-saving test known as the Pap smear. Here is a picture of his statue which can be seen today at the entrance of @WeillCornell Photo credit @jameshorowitzmd

0

13

56

Dr. Bishoy M. Faltas

@FaltasLab

3 months

Really enjoyed my time at @kochinstitute @MIT Great scientific discussions and collaboration opportunities Thanks to my wonderful and generous host @fjsanchezrivera !

1

2

56

Dr. Bishoy M. Faltas

@FaltasLab

2 years

FDA issues guidance on using ctDNA for solid tumor drug development 🧬💊

Olivier Elemento

@ElementoLab

2 years

Thank you @US_FDA for issuing draft guidelines for use of ctDNA in drug development for solid tumors in the early stage, non-metastatic setting. Will likely become standard for rapid patient selection and treatment response assessment

1

78

289

2

11

55

Dr. Bishoy M. Faltas

@FaltasLab

2 years

New #postdoc positions available in the Faltas Lab @WeillCornell #PhD #phd #postdoc #phdstudent #phdchat Please retweet!!!

1

28

54

Dr. Bishoy M. Faltas

@FaltasLab

3 years

Need transcriptomic profiling of FFPE tissues, but not sure about the best approach? check out our latest pre-print . We compared 3 RNA exome capture methods with RNAseq from fresh frozen samples @Kyrillus2 @iRonB25 @ElementoLab @asbonerw A. Alonso

Functional Comparison of Different Exome Capture-based Methods for Transcriptomic Profiling of...

Background The need for fresh frozen (FF) tissue limits implementing RNA sequencing (RNA-seq) in the clinic. The majority of clinical samples are processed in clinical laboratories and stored as...

www.medrxiv.org

5

14

55

Dr. Bishoy M. Faltas

@FaltasLab

8 months

Enjoyed hosting my friend @LDyrskjot for a brief visit to Weill Cornell from Denmark's @AarhusUni to discuss how to advance #bladdercancer research!

3

2

52

Dr. Bishoy M. Faltas

@FaltasLab

3 years

Our new paper is online @Nature_NPJ . Read the Tweetorial here:

Dr. Bishoy M. Faltas

@FaltasLab

3 years

Excited to share our new paper @Kyrillus2 @iRonB25 @davidwilkes1965 @PrincescaD @ElementoLab A. Alonso @asbonerw and others.

8

16

104

6

8

54

Dr. Bishoy M. Faltas

@FaltasLab

5 years

Enjoyed serving as a judge for medical student research day @WeillCornell . Very proud of medical student Lilly Gu who did a great job presenting her work in the Faltas lab over the summer. Thanks for @WCMC_CTSC for funding her summer fellowship.

2

4

54

Dr. Bishoy M. Faltas

@FaltasLab

2 years

Even more GU oncologists @PavlosMsaouel @OAlhalabiMD @ASCO #ASCO2022

4

2

53

Dr. Bishoy M. Faltas

@FaltasLab

4 months

Congratulations @DrChoueiri on advancing the needle once again for the treatment of patients with RCC! Huge achievement

Todd 〽️ Morgan, MD

@wandering_gu

4 months

Big moment!!! #GU24

1

9

41

0

9

52

Dr. Bishoy M. Faltas

@FaltasLab

5 years

Had a great time discussing our @NatureComms paper on upper tract urothelial cancer with @CaPsurvivorship in the context of published and ongoing work by @SurenaMatinMD @DrJohnSfakianos @PGrivasMDPhD @MattGalsky @JCensits @DSolit @montypal @urotoday

1

11

51

Dr. Bishoy M. Faltas

@FaltasLab

6 years

Proud to launch the @FaltasLab website We specialize in #bladdercancer #research #evolution @cornellGUcancer . Thanks to supporters @NIH @CDMRP @B_C_A_N @ConquerCancerFd . Our mission is to make discoveries to improve patients' lives.

1

11

50

Dr. Bishoy M. Faltas

@FaltasLab

3 months

Grateful for our new funding from the Irma T. Hirschl and Monique Weill-Caulier Research Award which will support our research for the next 5 years.

WCM Office of the Research Dean

@WCMResearch

3 months

Congratulations to Dr. @faltaslab on receiving an Irma T. Hirschl Career Scientist Award! @WCMEnglanderIPM @WCMGUcancer @WCMDeptofMed @WeillCornell

1

6

20

7

3

50

Dr. Bishoy M. Faltas

@FaltasLab

4 years

Looking forward to giving my first virtual Grand Rounds @YaleCancer

2

7

50

Dr. Bishoy M. Faltas

@FaltasLab

5 years

Happy to see our review on the evolution of treatment resistance in urothelial #bladdercancer finally in print @NatRevClinOncol @Panos_Vlach

3

12

50

Dr. Bishoy M. Faltas

@FaltasLab

4 years

I will be discussing the biology of upper tract urothelial carcinoma @UroOnc SUO webcast on July 18 @SurenaMatinMD @gorejohn -registration is free @BladderCancerUS @urotoday

Society of Urologic Oncology

@UroOnc

4 years

The program schedule and registration for the SUO Summer Virtual Webcast on July 18 are now available: . The webcast will feature lectures from the popular SUO Afternoon Session at the AUA. Registration is free!

0

4

23

2

11

49

Dr. Bishoy M. Faltas

@FaltasLab

2 years

Very proud of my postdoc @weisi_liu who was awarded the 2022 @BladderCancerUS YIA grant for his project to study therapeutic vulnerabilities in APOBEC3A-mutated #bladdercancer @WeillCornell @nyphospital @urotoday @OncoAlert #ProudPI

4

6

48

Dr. Bishoy M. Faltas

@FaltasLab

2 years

@PGrivasMDPhD came back to pay homage to his 🇬🇷compatriot and old friend Dr. Papanicolaou! @WCMEnglanderIPM @WeillCornell

4

48

Dr. Bishoy M. Faltas

@FaltasLab

3 years

Honored to be the discussant of three important abstracts at #ASCO21 by stars @PGrivasMDPhD , Sam Funt, and @tompowles1 . Looking fwd to reviewing progress in expanding immunotherapeutic approaches to a broader spectrum of #bladdercancer disease states @urotoday @WeillCornell @ASCO

1

10

49

Dr. Bishoy M. Faltas

@FaltasLab

2 years

GU oncologists back in force ! Great to catch up with @apolo_andrea @DrRanaMcKay @ZakhariaYousef #ASCO2022 @ASCO

2

48

Dr. Bishoy M. Faltas

@FaltasLab

6 months

Great to see my friend, collaborator and physician-scientist extraordinaire @jklee_lab @UrologySBUR #SBUR23

1

47

Dr. Bishoy M. Faltas

@FaltasLab

2 months

very interesting work showing role of APOBEC3C and D in restarting stalled replication forks. Highlighting diversity of roles with the APOBEC3 family.

Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic...

Nature Cancer - Ubhi et al. describe the contribution of APOBEC family members A3C and A3D in the gemcitabine resistance mechanism in the context of pancreatic cancer, which is mediated by...

www.nature.com

0

11

47